Adiponectin regulates bone marrow mesenchymal stem cell niche through a unique signal transduction pathway: An approach for treating bone disease in diabetes

Stem Cells

Volumn 33, Issue 1, 2015, Pages 240-252

  Yu, Liming ^a,b   Tu, Qisheng ^b   Han, Qianqian ^b   Zhang, Lan ^b   Sui, Lei ^b   Zheng, Leilei ^b   Meng, Shu ^b   Tang, Yin ^b   Xuan, Dongying ^b   Zhang, Jin ^b   Murray, Dana ^b   Shen, Qingping ^a   Cheng, Jessica ^b   Kim, Sung Hoon ^c   Dong, Lily Q ^d   Valverde, Paloma ^e   Cao, Xinming ^a   Chen, Jake ^b,f  

^a Shanghai Stomatological Disease Center   (China)

^b TUFTS UNIVERSITY SCHOOL OF DENTAL MEDICINE   (United States)

^c Kyung Hee University   (South Korea)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e WENTWORTH INSTITUTE OF TECHNOLOGY   (United States)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adiponectin; Bone regeneration; Cell mobilization; Mesenchymal stem cells

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; CASEIN KINASE II; CHEMOKINE RECEPTOR CXCR4; LEUCINE ZIPPER CONTAINING 1; MESSENGER RNA; PLECKSTRIN; PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; CXCL12 PROTEIN, MOUSE; CXCR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DISEASE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE REGENERATION; CELL MIGRATION; CELL NUCLEUS; CELL STIMULATION; CELL TRANSPORT; CHEMOTAXIS; CIRCULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; IMMUNOPRECIPITATION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; OBESITY; OSTEOBLAST; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEM CELL NICHE; TISSUE REPAIR; WOUND HEALING; 3T3 CELL LINE; ANIMAL; BONE DISEASES; BONE MARROW CELL; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; DIABETES MELLITUS, TYPE 2; GENETIC TRANSFECTION; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

MUS;

3T3 CELLS; ADIPONECTIN; ANIMALS; BONE DISEASES; BONE MARROW CELLS; CELL PROLIFERATION; CHEMOKINE CXCL12; DIABETES MELLITUS, TYPE 2; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; STEM CELL NICHE; TRANSFECTION;

EID: 84919421867     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1844     Document Type: Article

References (59)

1. Morrison SJ, Scadden DT,. The bone marrow niche for haematopoietic stem cells. Nature 2014; 505: 327-334.
2. Yin T,. The stem cell niches in bone. J Clin Invest 2006; 116: 1195-1201.
3. Méndez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829-834.
4. Ehninger A, Trumpp A,. The bone marrow stem cell niche grows up: Mesenchymal stem cells and macrophages move in. J Exp Med 2011; 208: 421-428.
5. Naveiras O, Nardi V, Wenzel PL, et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 2009; 460: 259-263.
6. DiMascio L, Voermans C, Uqoezwa M, et al. Identification of adiponectin as a novel hemopoietic stem cell growth factor. J Immunol 2007; 178: 3511-3520.
7. Mendez-Ferrer S, Lucas D, Battista M, et al. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008; 452: 442-447.
8. Wright DE, Wagers AJ, Gulati AP, et al. Physiological migration of hematopoietic stem and progenitor cells. Science 2001; 294: 1933-1936.
9. Petit I, Szyper-Kravitz M, Nagler A, et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002; 3: 687-694.
10. Katayama Y, Battista M, Kao WM, et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006; 124: 407-421.
11. Deng J, Zou ZM, Zhou TL, et al. Bone marrow mesenchymal stem cells can be mobilized into peripheral blood by G-CSF in vivo and integrate into traumatically injured cerebral tissue. Neurol Sci 2011; 32: 641-651.
12. Wan M, Li C, Zhen G, et al. Injury-activated transforming growth factor β controls mobilization of mesenchymal stem cells for tissue remodeling. Stem Cells 2012; 30: 2498-2511.
13. Kitaori T, Ito H, Schwarz EM, et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 2009; 60: 813-823.
14. Otsuru S, Tamai K, Yamazaki T, et al. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 2008; 26: 223-234.
15. Lapid K, Glait-Santar C, Gur-Cohen S, et al. Egress and mobilization of hematopoietic stem and progenitor cells: A dynamic multi-facet process. StemBook, ed. Cambridge, MA: The Stem Cell Research Community, StemBook, 2012: 1-37.
16. Devlin MJ, Rosen CJ,. The bone-fat interface: Basic and clinical implications of marrow adiposity. Lancet Diabetes Endocrinol 2014 Feb 19. pii: S2213-8587(14)70007-5. doi: 10.1016/S2213-8587(14)70007-5. [Epub ahead of print].
17. Sharma S, Tandon VR, Mahajan S, et al. Obesity: Friend or foe for osteoporosis. J Midlife Health 2014; 5: 6-9.
18. Hammoudi TM, Rivet CA, Kemp ML, et al. Three-dimensional in vitro tri-culture platform to investigate effects of crosstalk between mesenchymal stem cells, osteoblasts, and adipocytes. Tissue Eng Part A 2012; 18: 1686-1697.
19. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946.
20. Padmalayam I, Suto M,. Role of adiponectin in the metabolic syndrome: Current perspectives on its modulation as a treatment strategy. Curr Pharm Des 2013; 19: 5755-5763.
21. Villarreal-Molina MT, Antuna-Puente B,. Adiponectin: Anti-inflammatory and cardioprotective effects. Biochimie 2012; 94: 2143-2149.
22. Oshima K, Nampei A, Matsuda M, et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 2005; 331: 520-526.
23. Mitsui Y, Gotoh M, Fukushima N, et al. Hyperadiponectinemia enhances bone formation in mice. BMC Musculoskelet Disord 2011; 12: 18.
24. Lee HW, Kim SY, Kim AY, et al. Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells. Stem Cells 2009; 27: 2254-2262.
25. Wu Y, Tu Q, Valverde P, et al. Central adiponectin administration reveals new regulatory mechanisms of bone metabolism in mice. Am J Physiol Endocrinol Metab 2014; 306: E1418-1430.
26. Shibata R, Skurk C, Ouchi N, et al. Adiponectin promotes endothelial progenitor cell number and function. FEBS Lett 2008; 582: 1607-1612.
27. Chang J, Li Y, Huang Y, et al. Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway. Diabetes 2010; 59: 2949-2959.
28. Adams V, Heiker JT, Höllriegel R, et al. Adiponectin promotes the migration of circulating angiogenic cells through p38-mediated induction of the CXCR4 receptor. Int J Cardiol 2013; 167: 2039-2046.
29. Bellusci S, Fiaschi T, Giannoni E, et al. Globular adiponectin activates motility and regenerative traits of muscle satellite cells. PLoS One 2012; 7: e34782.
30. Dadson K, Chasiotis H, Wannaiampikul S, et al. Adiponectin mediated APPL1-AMPK signaling induces cell migration, MMP activation, and collagen remodeling in cardiac fibroblasts. J Cell Biochem 2014; 115: 785-793.
31. Lin YY, Chen CY, Chuang TY, et al. Adiponectin receptor 1 regulates bone formation and osteoblast differentiation by GSK-3beta/beta-Catenin signaling in mice. Bone 2014; 64: 147-154.
32. Luo XH, Guo LJ, Yuan LQ, et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 2005; 309: 99-109.
33. Kajimura D, Lee HW, Riley KJ, et al. Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. Cell Metab 2013; 17: 901-915.
34. Huang CY, Lee CY, Chen MY, et al. Adiponectin increases BMP-2 expression in osteoblasts via AdipoR receptor signaling pathway. J Cell Physiol 2010; 224: 475-483.
35. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 762-769.
36. Coope A, Milanski M, Araujo EP, et al. AdipoR1 mediates the anorexigenic and insulin/leptin-like actions of adiponectin in the hypothalamus. FEBS Lett 2008; 582: 1471-1476.
37. Mao X, Kikani CK, Riojas RA, et al. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol 2006; 8: 516-523.
38. Xu Y, Wang N, Ling F, et al. Receptor for activated C-kinase 1, a novel binding partner of adiponectin receptor 1. Biochem Biophys Res Commun 2009; 378: 95-98.
39. Charlton HK, Webster J, Kruger S, et al. ERp46 binds to AdipoR1, but not AdipoR2, and modulates adiponectin signalling. Biochem Biophys Res Commun 2010; 392: 234-239.
40. Heiker JT, Wottawah CM, Juhl C, et al. Protein kinase CK2 interacts with adiponectin receptor 1 and participates in adiponectin signaling. Cell Signal 2009; 21: 936-942.
41. Juhl C, Morl K, Beck-Sickinger AG,. Adiponectin receptor 1 interacts with both subunits of protein kinase CK2. Mol Cell Biochem 2011; 356: 185-189.
42. Ferraro F, Lymperi S, Mendez-Ferrer S, et al. Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med 2011; 3: 104ra101.
43. DiPersio JF,. Diabetic stem-cell "mobilopathy". N Engl J Med 2011; 365: 2536-2538.
44. Fadini GP, Albiero M, Vigili de Kreutzenberg S, et al. Diabetes impairs stem cell and proangiogenic cell mobilization in humans. Diabetes Care 2013; 36: 943-949.
45. Tepper OM, Carr J, Allen RJ, et al. Decreased circulating progenitor cell number and failed mechanisms of stromal cell-derived factor-1 mediated bone marrow mobilization impair diabetic tissue repair. Diabetes 2010; 59: 1974-1983.
46. Albiero M, Poncina N, Tjwa M, et al. Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1. Diabetes 2014; 63: 1353-1365.
47. Farr JN, Drake MT, Amin S, et al. In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J Bone Miner Res 2014; 29: 787-795.
48. Manavalan JS, Cremers S, Dempster DW, et al. Circulating osteogenic precursor cells in type 2 diabetes mellitus. J Clin Endocrinol Metab 2012; 97: 3240-3250.
49. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935.
50. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599.
51. Tu Q, Zhang J, Dong LQ, et al. Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1. J Biol Chem 2011; 286: 12542-12553.
52. Ye JH, Xu YJ, Gao J, et al. Critical-size calvarial bone defects healing in a mouse model with silk scaffolds and SATB2-modified iPSCs. Biomaterials 2011; 32: 5065-5076.
53. Tu Q, Valverde P, Li S, et al. Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone. Tissue Eng 2007; 13: 2431-2440.
54. Wang B, Yang Y, Liu L, et al. NHERF1 regulation of PTH-dependent bimodal Pi transport in osteoblasts. Bone 2013; 52: 268-277.
55. Bakker AD, Klein-Nulend J,. Osteoblast isolation from murine calvaria and long bones. Methods Mol Biol 2012; 816: 19-29.
56. Zhang J, Tu Q, Bonewald LF, et al. Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J Bone Mine Res 2011; 26: 1953-1963.
57. Zhu W, Liang G, Huang Z, et al. Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development. J Biol Chem 2011; 286: 26794-26805.
58. Bragdon B, Thinakaran S, Moseychuk O, et al. Casein kinase 2 beta-subunit is a regulator of bone morphogenetic protein 2 signaling. Biophys J 2010; 99: 897-904.
59. Moseychuk O, Akkiraju H, Dutta J, et al. Inhibition of CK2 binding to BMPRIa induces C2C12 differentiation into osteoblasts and adipocytes. J Cell Commun Signal 2013; 7: 265-278.